Contains sulfadiazine/trimethoprim 400 mg/ml (333 mg sulfadiazine and 67 mg trimethoprim). Proven effective in horses for the
treatment of lower respiratory tract infections caused by susceptible strains of Streptococcus equi subsp. zooepidemicus. Safety
was demonstrated in a controlled study in horses at 1x, 3x and 5x the recommended dose for 30 days. Easy-to-use liquid formulation.
Significantly higher bioavailability on a mg-to-mg basis compared to an existing approved paste product, based on a pharmokinetic
crossover study. Low incidence of side effects in controlled safety studies.
treatment of lower respiratory tract infections caused by susceptible strains of Streptococcus equi subsp. zooepidemicus. Safety
was demonstrated in a controlled study in horses at 1x, 3x and 5x the recommended dose for 30 days. Easy-to-use liquid formulation.
Significantly higher bioavailability on a mg-to-mg basis compared to an existing approved paste product, based on a pharmokinetic
crossover study. Low incidence of side effects in controlled safety studies.
- (Loading SDS PDF) SDS Sheet